Our top docs produce better health outcomes

The Mid-Atlantic Permanente Medical Group (MAPMG) is the nation’s leading group of doctors, and they exclusively treat Kaiser Permanente members. With 1,800+ doctors, many of whom are recognized as top doctors, it’s the largest medical group in Maryland, Virginia and Washington, DC.¹ Unlike traditional health care, our doctors earn competitive salaries instead of fees for each service they perform, which means they work directly with patients — not administrators — to make care decisions. The results speak for themselves.

We keep our patients healthier

Our patients have lower diabetes mortality rates compared to national benchmarks. Lower hypertension mortality rates. Lower breast cancer, colon cancer, and cervical cancer mortality rates.² Simply put, our patients lead longer, healthier lives.

What you get with KP

Top-rated health plan in the region

We’re the only commercial health plan in Maryland, Virginia, and Washington, DC — and one of only two plans in the nation — to be rated 5 out of 5 stars by the NCQA.³

Award-winning, highly recognized physicians

What you get with KP

Top-rated health insurance in the nation

We’re rated #1 overall among 70+ insurance carriers by Insure.com.⁵

Only elite doctors work at Kaiser Permanente

Permanente physicians undergo a rigorous screening process before being hired. They must be board-certified or earn board certification shortly after joining MAPMG, so they’ve had additional training in their specialty. Their work is then constantly monitored and evaluated, so only the best are providing you care.

What you get with KP

Only 1 in 5 applicants becomes a Permanente physician

The Mid-Atlantic Permanente Medical Group recruits physicians exclusively from the top medical schools in the country.

Kaiser Permanente is the region’s leading health system, with our quality of care and service recognized by many organizations.

In the survey Best Health Insurance Companies of 2024 by Insure.com, Kaiser Permanente as a national enterprise is rated #1 overall among 70+ competitors—for the fourth year in a row. In the NCQA Commercial Health Plan Ratings 2023, our commercial plan is rated 5 out of 5, the highest rating in the region. The 2022 Commission on Cancer, a program of the American College of Surgeons, granted Three-Year Accreditation with Commendation to the Kaiser Permanente cancer care program. The Mid-Atlantic Permanente Medical Group is the largest multispecialty medical group in the Washington, DC, and Baltimore areas and exclusively treats Kaiser Permanente members. Permanente doctors are recognized as Top Doctors in Northern Virginia Magazine (2024), Arlington Magazine (2023), Baltimore magazine (2023), Bethesda magazine (2023), and Washingtonian magazine (2023). According to NCQA’s Quality Compass® 2023, we’re rated 5 out of 5 in 31 care measures, including: controlling high blood pressure, glucose control and blood pressure control (140/90) for diabetes, breast cancer screening, colorectal cancer screening, childhood and adolescent immunizations, and postpartum care. Quality Compass is a registered trademark of the NCQA.

The physicians who practice at Kaiser Permanente are recognized as Top Doctors in Arlington Magazine (2023), Baltimore magazine (2023), Bethesda magazine (2023), Northern Virginia Magazine (2024), and Washingtonian magazine (2023).
NCQA Commercial Health Plan Ratings 2023. The source for certain health plan measure rates and benchmark (averages and percentiles) data (“the Data”) is Quality Compass® 2023 and is used with the permission of the National Committee for Quality Assurance (“NCQA”). Any analysis, interpretation or conclusion based on the Data is solely that of the authors, and NCQA specifically disclaims responsibility for any such analysis, interpretation or conclusion. Quality Compass is a registered trademark of NCQA. The Data comprises audited performance rates and associated benchmarks for Healthcare Effectiveness Data and Information Set measures (“HEDIS®”) and HEDIS CAHPS® survey measure results. HEDIS measures and specifications were developed by and are owned by NCQA. HEDIS measures and specifications are not clinical guidelines and do not establish standards of medical care. NCQA makes no representations, warranties or endorsement about the quality of any organization or clinician who uses or reports performance measures, or any data or rates calculated using HEDIS measures and specifications, and NCQA has no liability to anyone who relies on such measures or specifications. NCQA holds a copyright in Quality Compass and the Data and may rescind or alter the Data at any time. The Data may not be modified by anyone other than NCQA. Anyone desiring to use or reproduce the Data without modification for an internal, noncommercial purpose may do so without obtaining approval from NCQA. All other uses, including a commercial use and/or external reproduction, distribution or publication, must be approved by NCQA and are subject to a license at the discretion of NCQA. 2023 National Committee for Quality Assurance, all rights reserved. CAHPS is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ). Official plan name per Quality Compass: Kaiser Foundation Health Plan of the Mid-Atlantic States, Inc.
In the NCQA Commercial Health Plan Ratings 2023, our commercial plan is rated 5 out of 5, the highest rating in the region.
The 2022 Commission on Cancer, a program of the American College of Surgeons, granted Three-Year Accreditation with Commendation to the Kaiser Permanente cancer care program.
In the survey Best Health Insurance Companies of 2024 by Insure.com, Kaiser Permanente as a national enterprise is rated #1 overall among 70+ insurance carriers.